Motivated by our motto, "Good Health Can't Wait," we are dedicated to granting access to innovative and reasonably priced medications.
Our offerings span our primary business segments, which include Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars, and global over-the-counter pharmaceutical goods. In the fields of gastroenterology, cardiology, diabetology, oncology, pain management, and dermatology, we strive to address unmet patient requirements. We are making investments in industries that will shape the future, such as digital healthcare, clinically distinct assets, and drug discovery.
Our work is founded on our deep research capabilities, which allow us to innovate for patients. Our efforts in intricate biology and chemistry have produced multiple firsts. We were among the first in India to introduce numerous novel compounds and export APIs on a large scale. In the 1990s, we were the first in India to start a novel drug discovery program, and in the 2000s, the USFDA granted us 180 days of exclusivity. Being the first in the industry helps us keep our word and fulfill our commitments.
We are the ones that introduced "Self-Managed Teams" to the pharmaceutical industry. With the help of programs like our "New Horizons Leadership Programme," we cultivate leaders. Our investment in human capital benefits the industry as a whole in addition to our business. On our path toward diversity, equity, and inclusion, we have set high standards for ourselves. Our goal is to establish an atmosphere where individuals may reach their maximum potential by working hard and never stopping learning.